ApoA-V gene transfer in APOC3 transgenic mice lowers triglycerides and promotes cholesterol redistribution from VLDL to larger HDL particles, highlighting its role in modulating HDL maturation.
No takes yet. Share an insight, caveat, or question.
ApoA-V lipid effects in animal models are hypothesis-generating; leaves open therapeutic translation to human dyslipidemia.
Qu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: